The safety and accuracy of sentinel-node biopsy in early-stage invasive breast cancer - Turkish experience

Journal of Investigative Surgery

Volumn 18, Issue 3, 2005, Pages 129-134

  Kebudi, Abut ^a,d,f   Işgör, Adnan ^a,e   Atay, Murat ^b   Yetkin, Gürkan ^a   Yazici, Dehan ^c   Yildiz, Aygün ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

^c Kartal Training and Research Hospital   (Turkey)

^d MALTEPE UNIVERSITY   (Turkey)

^e HALIC UNIVERSITY   (Turkey)

^f General Surgery Department   (Turkey)

Author keywords

Axillary lymph nodes; Breast carcinoma; Metastases; Sentinel node

Indexed keywords

TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST RECONSTRUCTION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SAFETY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; TREATMENT OUTCOME; TURKEY;

EID: 22944487022     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930590956165     Document Type: Article

References (44)

1. Schreer I, Frischbier HJ. Breast cancer screening projects: Results. In: Friedrich M, Sickles AE, eds. Radiological Diagnosis of Breast Diseases. Berlin-Heidelberg: Springer; 2000:333-347.
2. Heywang-Köbrunner SH, Dershaw D, Schreer I. Diagnostic Imaging, 2nd ed. Ludwigsburg: Thieme; 2001:338-395.
3. Turner DA. MR spectroscopy and imaging of breast cancer: A brief history. Magn Resonance Imaging Clin North Am. 1994:4:505-510.
4. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J Clin. 2002:52(1):23-47.
5. Ries LA, Wingo PA, Miller DS, et al. SEER Cancer Statistics Review 1973-1997. Bethesda, MD: National Cancer Institute; 2000.
6. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24.740 breast cancer cases. Cancer. 1989;63:181-187.
7. Nasser IA, Lee AK, Bosari S, SaganichR, Heatley G, Silverman ML. Occult axillary lymph node metastases in "node negative" breast carcinoma. Hum Pathol. 1993;24:950-957.
8. Allred DC, Elledge RM. Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes. Cancer. 1999;86:905-907.
9. Koller M, Barsuk D, Zippel D, Engelberg S, Ben-Ari G, Papa MZ: Sentinel lymph node involvement - A predictor for axillary node status with breast cancer - Has the time come? Eur J Surg Oncol. 1998;24(3):166-168.
10. Veronesi U, Pagenelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. JNCI. 1999;91:368-373.
11. Warmuth MA, Bowen G, Prosnitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey. Cancer. 1998;83:1362-1368.
12. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg. 1999;30(2):194-201.
13. Vaggelli V, Castagnoli A, Distante V, Orzalesi L, Cataliotti L, Cesco P. Lymphoscintigraphy and gamma probe tracing in detecting breast cancer lymph node involvement: Can they replace axillary lymph node dissection? Tumori. 2000;86(4):322-324.
14. Marrow M. Sentinel lymph node dissection for breast cancer. Postgraduate Course 22. 85th Annual Clinical Congress; American Collage of Surgeons; October 10-15, San Francisco, CA. 1999:38-40.
15. Fisher B, Redmund C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-681.
16. Sener SF. Sentinel lymphadenectomy for breast cancer. A standard of surgical care? Cancer Pract. 2000;8:195-196.
17. Fraile M, Rull M, Fuste F, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: An approach to its validity. Ann Oncol. 2000;11:701-705.
18. Noguchi M, Tsugawa K, Bando E, et al. Sentinel lymphadenectomy in breast cancer:identification of sentinel lymph node and detection of metastases. Breast Cancer Res Treat. 1999;53:97-104.
19. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-466.
20. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
21. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
22. Alex JC, Krag DN. Gamma probe guided localization of lymph nodes. Surg Oncol. 1993;2:137-143.
23. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
24. Leidenius M, Leppanen E, Krogerus L, von Smitten K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg. 2003;185:127-130.
25. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ. Sentinel-lymph-node biopsy for breast cancer - Not yet the standard of care. N Engl J Med. 1998;339:990-995.
26. Kopans DB. Screening for breast cancer. In: Singletary SE, Robb GL, eds. Advanced Therapy of Breast Disease.St. Louismo: B. C. Decker; 2000:1-8.
27. Fisher B, Fisher ER. Transmigration of lymph nodes by tumor cells. Science. 1966;152:1397-1398.
28. Fisher B, Fisher ER. The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet. 1966;122:791-798.
29. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229-2234.
30. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-positive breast cancer: The curability of small cancers with a limited number of positive nodes. J Clin Oncol. 1996;14:3105-3111.
31. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet. 1970; 131:79-88.
32. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC. Value of dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institute Curie. Lancet. 1992;339:1245-1248.
33. Dookeran KA, Sikora SS. How should the axilla be treated in breast cancer? Eur J Surg Oncol. 1995;21:435-436.
34. Polednak AP. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg. 2003;237:163-167.
35. Cady B. Consensus on sentinel node biopsy. Breast J. 2002;8:123-125.
36. Moonka R, Hunter JA, Cray WK Jr, Duncan M, Wechter DG. A comparison of rates of lymph node metastases between patients undergoing sentinel and axillary lymphadenectomy. Am J Surg. 2002; 183:558-561.
37. Wong SL, Chao C, Edwards MJ, McMasters KM. Lymphatic mapping and sentinel node biopsy. In: Donegan WL, Spratt JS, eds. Cancer of the Breast, 5th ed. St. Louis, Mo; Saunders; 2002:567-578.
38. Uren RF, Howman-Giles RB, Thompson JF. Mammary lymphoscintigraphy in breast cancer. J Nucl Med. 1995; 36:1775-1780.
39. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med. 1997;38:366-368.
40. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560-2566.
41. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques. Ann Surg. 2001;234:292-300.
42. Wong SL, Edwards MS, Chao C, et al. Sentinel lymph node biopsy for breast cancer: Impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192:684-691.
43. van der Wall E. The sentinel node in breast cancer: Implications for adjuvant treatment? Eur J Nucl Med. 1999;26:S17-19.
44. Cox CE, Salud CJ, Harrinton MA. The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am. 2000;80:1759-1777.